Neko Health raises $700M as it prepares for US expansion

Neko Health, the body-scanning and health assessment startup co-founded by Spotify’s Daniel Ek and Hjalmar Nilsonne, has raised a $700 million Series C funding round led by Lightspeed Venture Partners and O.G. Venture Partners. Series C rounds typically fund a startup’s growth-stage expansion, following earlier seed and Series A/B financing.

The company’s technology couples proprietary body-scanning with bloodwork to assess a person’s health, and it can integrate Apple Health data, which Hjalmar Nilsonne says gives its medical clinicians real-world data to use in assessments. Neko currently operates in the UK and Sweden and is preparing to open its first U.S. location in New York. The company says more than 100,000 people have already had scans, while more than 350,000 people have registered for the waitlist or set an appointment.

The $700 million round follows a $260 million Series B that Neko raised in January 2025 — another growth-stage funding round. The practical value of the scans was recently underscored by Calm founder Alex Tew, who had a Neko Health scan that found a malignant mole on his back. “I’m grateful to Neko for helping me discover this – I’m not sure how I would have otherwise,” Tew said.

Neko isn’t the only tech-founded venture moving into body scanning. MidJourney, the AI lab known for its image and video generation model, is also creating a body scanner, which it plans to integrate into a spa experience with hot tubs and saunas, opening in San Francisco sometime in 2027.

Other investors in Neko Health’s Series C include:

• Atomico
• General Catalyst
• Lakestar
• Liberty City Ventures
• Positive Sum
• BDT & MSD

Why it matters

Neko Health’s $700 million round signals deep investor confidence in preventative, tech-driven healthcare, setting up a high-stakes expansion into the competitive U.S. market.